These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 21691438)

  • 41. In-silico design and ADMET predictions of some new imidazo[1,2-a]pyridine-3-carboxamides (IPAs) as anti-tubercular agents.
    Abdullahi M; Das N; Adeniji SE; Usman AK; Sani AM
    J Clin Tuberc Other Mycobact Dis; 2021 Dec; 25():100276. PubMed ID: 34568589
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Design, synthesis and biological evaluation of imidazo[2,1-b]thiazole and benzo[d]imidazo[2,1-b]thiazole derivatives as Mycobacterium tuberculosis pantothenate synthetase inhibitors.
    Samala G; Devi PB; Saxena S; Meda N; Yogeeswari P; Sriram D
    Bioorg Med Chem; 2016 Mar; 24(6):1298-307. PubMed ID: 26867485
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Novel indolinone-tethered benzothiophenes as anti-tubercular agents against MDR/XDR M. tuberculosis: Design, synthesis, biological evaluation and in vivo pharmacokinetic study.
    Eldehna WM; Mahmoud ST; Elshnawey ER; Elsayed ZM; Majrashi TA; El-Ashrey MK; Rashed M; Hemeda LR; Shoun AA; Elkaeed EB; El Hassab MA; Abdel-Aziz MM; Shahin MI
    Bioorg Chem; 2024 Feb; 143():107009. PubMed ID: 38070474
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis and in vitro antitubercular activity of pyridine analouges against the resistant Mycobacterium tuberculosis.
    Patel H; Chaudhari K; Jain P; Surana S
    Bioorg Chem; 2020 Sep; 102():104099. PubMed ID: 32711084
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis and antitubercular evaluation of novel dibenzo[b,d]thiophene tethered imidazo[1,2-a]pyridine-3-carboxamides.
    Pulipati L; Sridevi JP; Yogeeswari P; Sriram D; Kantevari S
    Bioorg Med Chem Lett; 2016 Jul; 26(13):3135-3140. PubMed ID: 27184765
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 3-Aryl-substituted imidazo[1,2-a]pyridines as antituberculosis agents.
    Karale UB; Shinde AU; Babar DA; Sangu KG; Vagolu SK; Eruva VK; Jadav SS; Misra S; Dharmarajan S; Rode HB
    Arch Pharm (Weinheim); 2021 Oct; 354(10):e2000419. PubMed ID: 34185337
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Exploration of Isoxazole-Carboxylic Acid Methyl Ester Based 2-Substituted Quinoline Derivatives as Promising Antitubercular Agents.
    Kumar Sahoo S; Naiyaz Ahmad M; Kaul G; Nanduri S; Dasgupta A; Chopra S; Madhavi Yaddanapudi V
    Chem Biodivers; 2022 Jul; 19(7):e202200324. PubMed ID: 35653161
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vitro and in vivo activities of the nitroimidazole TBA-354 against Mycobacterium tuberculosis.
    Upton AM; Cho S; Yang TJ; Kim Y; Wang Y; Lu Y; Wang B; Xu J; Mdluli K; Ma Z; Franzblau SG
    Antimicrob Agents Chemother; 2015 Jan; 59(1):136-44. PubMed ID: 25331696
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Preliminary evaluation of anti-tuberculosis potential of siderophores against drug-resistant Mycobacterium tuberculosis by mycobacteria growth indicator tube-drug sensitivity test.
    Gokarn K; Pal RB
    BMC Complement Altern Med; 2017 Mar; 17(1):161. PubMed ID: 28327117
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthesis and Antibacterial Activity of Mefloquine-Based Analogs Against Sensitive and Resistant Mycobacterium tuberculosis Strains.
    da Silva Araújo A; Moraes AM; Lourenço MCS; Pessoa CO; da Silva ET; de Souza MVN
    Curr Top Med Chem; 2019; 19(9):683-689. PubMed ID: 30836914
    [TBL] [Abstract][Full Text] [Related]  

  • 51. New Route to the Synthesis of Novel Pyrazolo[1,5-a]pyrimidines and Evaluation of their Antimicrobial Activity as RNA Polymerase Inhibitors.
    Abdallah AEM; Elgemeie GH
    Med Chem; 2022; 18(9):926-948. PubMed ID: 35236270
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Design, synthesis, and bioevaluation of a novel class of (E)-4-oxo-crotonamide derivatives as potent antituberculosis agents.
    Ren J; Xu J; Zhang G; Xu C; Zhao L; You X; Wang Y; Lu Y; Yu L; Wang J
    Bioorg Med Chem Lett; 2019 Feb; 29(4):539-543. PubMed ID: 30630715
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Naphthoquinones isolated from Diospyros anisandra exhibit potent activity against pan-resistant first-line drugs Mycobacterium tuberculosis strains.
    Uc-Cachón AH; Borges-Argáez R; Said-Fernández S; Vargas-Villarreal J; González-Salazar F; Méndez-González M; Cáceres-Farfán M; Molina-Salinas GM
    Pulm Pharmacol Ther; 2014 Feb; 27(1):114-20. PubMed ID: 23968826
    [TBL] [Abstract][Full Text] [Related]  

  • 54.
    Antoci V; Cucu D; Zbancioc G; Moldoveanu C; Mangalagiu V; Amariucai-Mantu D; Aricu A; Mangalagiu II
    Future Med Chem; 2020 Feb; 12(3):207-222. PubMed ID: 31916456
    [No Abstract]   [Full Text] [Related]  

  • 55. Design, synthesis and anti-Mycobacterium tuberculosis evaluation of new thiazolidin-4-one and thiazolo[3,2-a][1,3,5]triazine derivatives.
    Younis MH; Mohammed ER; Mohamed AR; Abdel-Aziz MM; Georgey HH; Abdel Gawad NM
    Bioorg Chem; 2022 Jul; 124():105807. PubMed ID: 35487073
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Design, Synthesis and Antimycobacterial Activity of Novel Imidazo[1,2-a]pyridine Amide-Cinnamamide Hybrids.
    Li L; Li Z; Liu M; Shen W; Wang B; Guo H; Lu Y
    Molecules; 2015 Dec; 21(1):E49. PubMed ID: 26729085
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Design, synthesis and antimycobacterial activity of less lipophilic Q203 derivatives containing alkaline fused ring moieties.
    Wang A; Wang H; Geng Y; Fu L; Gu J; Wang B; Lv K; Liu M; Tao Z; Ma C; Lu Y
    Bioorg Med Chem; 2019 Mar; 27(5):813-821. PubMed ID: 30692025
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Syntheses and studies of deuterated Imdiazo[1,2-a]pyridine-3-carboxamides with potent anti-tuberculosis activity and improved metabolic properties.
    Liu R; Marshall K; Ma R; Lien Thi Pham K; Shetye G; Liu Z; Cho S; Jeong H; Franzblau SG; Moraski GC; Miller MJ
    Bioorg Chem; 2022 Nov; 128():106074. PubMed ID: 35987188
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Discovery of quinolone derivatives as antimycobacterial agents.
    Liu KL; Teng F; Xiong L; Li X; Gao C; Yu LT
    RSC Adv; 2021 Jul; 11(39):24095-24115. PubMed ID: 35479020
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.